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Abstract. 
 
The endothelium is morphologically and 
functionally adapted to meet the unique demands of 
the underlying tissue. At the present time, little is 
known about the molecular basis of endothelial cell di-
versity. As one approach to this problem, we have cho-
sen to study the mechanisms that govern differential 
expression of the endothelial cell–restricted von Wille-
brand factor (vWF) gene. Transgenic mice were gener-
ated with a fragment of the vWF gene containing 2,182 
bp of 5
 
9
 
 flanking sequence, the first exon and first in-
tron coupled to the 
 
LacZ
 
 reporter gene. In multiple in-
dependent lines of mice, 
 
b
 
-galactosidase expression 
was detected within endothelial cells in the brain, heart, 
and skeletal muscle. In isogeneic transplantation mod-
els, 
 
LacZ
 
 expression in host-derived auricular blood 
vessels was specifically induced by the microenviron-
ment of the heart. In in vitro coculture assays, expres-
sion of both the transgene and the endogenous vWF 
gene in cardiac microvascular endothelial cells 
(CMEC) was upregulated in the presence of cardiac 
myocytes. In contrast, endothelial cell levels of throm-
bomodulin protein and mRNA were unchanged by the 
addition of ventricular myocytes. Moreover, CMEC ex-
pression of vWF was not influenced by the addition of 
3T3 fibroblasts or mouse hepatocytes. Taken together, 
the results suggest that the vWF gene is regulated by 
vascular bed–specific pathways in response to signals 
derived from the local microenvironment.
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T
 
he 
 
endothelium exhibits a remarkable diversity of
cellular properties that are uniquely adapted to the
needs of the underlying tissue. Heterogeneity within
the endothelium has been described at the level of cell
structure, antigen composition, mRNA expression, and
cell function (Gerritsen, 1987; Kumar et al., 1987; Turner
et al., 1987; Tomlinson et al., 1991; Page et al., 1992; Ger-
ritsen and Bloor, 1993). For example, the postcapillary,
high venule endothelial cells in lymphoid organs support
the binding and migration of lymphocytes via the specific
interaction of adhesion molecules with lymphocyte hom-
ing receptors (Streeter et al., 1988; Berg et al., 1989; Gi-
rard and Springer, 1995). On the other hand, the endothe-
lial cells that line the small blood vessels of the brain
possess a unique expression pattern of cell surface recep-
tors, transporters, and intracellular enzymes that serve to
tightly regulate the exchange of solutes between blood and
brain parenchyma (Bradbury, 1993; Schlosshauer, 1993).
Distinct endothelial cell phenotypes have also been docu-
mented in other organs such as the liver, kidney, and lung
(DeFouw, 1988; Fleming and Jones, 1989). In addition, the
endothelium has been shown to vary in its response to
pathophysiological stimuli. 
 
Escherichia coli
 
–induced sepsis
in baboons results in the selective activation of tissue fac-
tor in a subpopulation of endothelial cells within the mar-
ginal zone of splenic follicles (Drake et al., 1993). In mice,
the systemic delivery of lipopolysaccharide results in a
specific upregulation of the pentraxin gene family mem-
ber, 
 
ptx-3
 
, specifically within the vascular beds of the heart
and skeletal muscle (Introna et al., 1996). These and other
examples of the vascular bed–specific endothelial cell re-
sponse underscore the potential role of phenotypic hetero-
geneity in mediating focal vasculopathic disease states.
Beyond a large descriptive catalogue of endothelial cell
phenotypes, surprisingly little is known about the molecu-
lar basis of vascular diversity. An important question that
continues to elude us is whether the phenotypic patterns
are genetically inherited from distinct sublineages or
rather governed by signals residing within the microenvi-
ronment. In vitro investigations using embryonic stem cell
cultures suggest that endothelial cell differentiation and
early vasculogenesis are genetically predetermined (Wang
et al., 1992). Retroviral cell tagging studies in chicken em-
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bryos have shown different clonal origins for endocardial
versus coronary artery endothelial cells (Mikawa and Fisch-
man, 1992). On the other hand, in vivo transplant studies
using avian species have pointed to the critical role of en-
vironmental cues in establishing blood vessel patterning
during development (Poole and Coffin, 1989; Noden,
1990). Unfortunately, these experimental approaches are
difficult to adapt to the mammalian system, owing to poor
accessibility of embryos and the lack of appropriate cell
markers. Nevertheless, there is evidence that regional spe-
cialization of the endothelium in mammals may be condi-
tioned by exogenous factors. Perhaps the best examples
are found in studies of the blood–brain barrier, in which
both in vitro culture and in vivo transplant studies have
documented the ability of astrocytes to induce the appro-
priate phenotype in endothelial cells (Stewart and Wiley,
1981; Beck et al., 1984; Janzer and Raff, 1987; Maxwell et
al., 1987; Tao-Cheng et al., 1987; Lobrinus et al., 1992).
Additional studies have demonstrated a direct influence of
extracellular signals on gene expression in other endothe-
lial cell types. For example, preproendothelin-1 mRNA in
rat cardiac microvascular endothelial cells was found to be
upregulated when these cells were grown in coculture with
ventricular myocytes (Nishida et al., 1993). Shear stress
has been shown to modulate the transcription of a number
of endothelial cell genes through the induction of specific
DNA–protein interactions (Resnick et al., 1993; Resnick
and Gimbrone, 1995). At this time, it is not clear what role
these and other examples of modulatable gene expression
play in establishing and/or maintaining the phenotype of a
given endothelial cell in the intact animal.
Regardless of the relative roles of clonality and environ-
ment in mediating phenotypic differences within the en-
dothelium, the establishment and maintenance of vascular
diversity is ultimately controlled at a transcriptional level.
Regulation of endothelial cell gene expression has been
shown to vary between blood vessel types and vascular
beds (Bahnak et al., 1989; Hadley et al., 1994; Kaipainen et
al., 1995; Lassalle et al., 1996; Smith et al., 1996). For ex-
ample, the multimeric glycoprotein von Willebrand factor
(vWF),
 
1
 
 a cofactor for platelet adhesion and a carrier for
the antihemophiliac factor (for review see Sadler, 1991;
Ruggeri and Ware, 1993), is heterogeneously distributed
throughout the vascular tree and is associated with re-
gional variations in mRNA levels (Rand et al., 1987; Wu et
al., 1987; Bahnak et al., 1989; Coffin et al., 1991; Page et
al., 1992; Smith et al., 1996; Aird, W., and R.D. Rosenberg,
unpublished results). vWF is expressed at higher levels on
the venous side of the circulation compared with arteries
and arterioles. By contrast, consistently low levels of vWF
are present within the sinusoidal endothelial cells of the
liver and spleen. In en face preparations of the rat aorta,
expression of vWF appears to vary from one endothelial
cell to another (Senis et al., 1996). The gene product is
present in clusters of endothelial cells oriented along the
longitudinal axis of blood flow and is particularly concen-
trated in endothelial cells lining the ostia of the intercostal
arteries. The administration of thrombin resulted in an in-
crease of histochemically detected vWF expression, sug-
gesting that previously nonexpressing endothelial cells
may be recruited to produce vWF (Senis et al., 1996).
Taken together, the available evidence suggests that the
transcriptional control of vWF varies from one endothelial
cell to another and that cell-to-cell variation may be pro-
grammed by the extracellular environment. Indeed, an un-
derstanding of how these transcriptional networks operate
selectively in subsets of endothelial cells should provide an
initial framework with which to unravel the molecular
mechanisms of differential gene expression and endothe-
lial cell heterogeneity.
Until recently, little was known about the transcrip-
tional regulation of vWF. In transgenic mice, a segment of
the human vWF gene containing 487 bp of 5
 
9
 
 flanking se-
quence, as well as the first exon (
 
1
 
1 – 
 
1
 
246) was found to
direct expression to a subpopulation of endothelial cells in
the adult brain (Aird et al., 1995). These observations sug-
gested that the transgene is under vascular bed–specific
transcriptional control and implied that more widespread
expression of the vWF gene might be dependent on pro-
moter sequences either proximal to or distal to the 733-bp
fragment. To test this hypothesis, a larger segment of the
vWF gene containing 2,182 bp of 5
 
9
 
 flanking sequence, the
first exon, and the first intron was coupled to the 
 
LacZ
 
 re-
porter gene, and the resulting construct (vWF
 
lacZ
 
-2) was
used to generate additional lines of transgenic mice. As we
report below, transgene expression in these mice was de-
tected not only within blood vessels of the brain but also
within the microvasculature of the heart and skeletal mus-
cle. These findings indicate that vWF expression is indeed
regulated by distinct organ-specific transcriptional path-
ways. We also show by transplantation and coculture tech-
niques that cardiac vascular bed–specific control of the
vWF transgene and the endogenous gene is modulated by
interactions between microvascular endothelial cells and
cardiomyocytes. The results support the existence of
novel, tissue-specific pathways that regulate the function
of endothelial cells in response to signals derived from
their local microenvironment.
 
Materials and Methods
 
Generation and Analysis of Transgenic Mice
 
The vWF sequence in vWF
 
lacZ
 
-2 was cloned from a human genomic li-
brary (Stratagene, La Jolla, CA). Through sequential cloning steps, the se-
quence including 2,182 bp of 5
 
9
 
 flanking sequence, the first exon, the first
intron, and the translational start site of the human vWF gene was cou-
pled to the SDK sequence, 
 
LacZ
 
 cDNA and simian virus polyadenylation
signal of pSDK
 
lac
 
ZpA (generous gift from J. Rossant, Mount Sinai Hos-
pital, Toronto, Canada). The generation and identification of transgenic
mice as well as the analysis of tissue sections and whole mounts for 
 
LacZ
 
activity and vWF immunohistochemistry were carried out as previously
described (Aird et al., 1995). For reverse transcriptase (RT)-PCR, total
RNA isolation was isolated from vWF
 
lacZ
 
-2 mouse organs using a guani-
dinium thiocyanate phenol–chloroform single-step extraction (Strat-
agene). Approximately 10 
 
m
 
g of total RNA from each organ was treated
with DNase and then incubated with reverse transcriptase in the presence
of [
 
32
 
P]dCTP. First strand cDNA was then used as template for PCR with
primer sets specific for 
 
E. coli
 
 
 
LacZ
 
 (5
 
9
 
-GCATCGAGCTGGGTAATAA
GCGTTGGCAAT-3
 
9
 
, 5
 
9
 
-GACACCAGACCAACTGGTAATGGTAG-
CGAC-3
 
9
 
), mouse vWF (5
 
9
 
-ATGATGGAGAGGTTACACATC-3
 
9
 
, 5
 
9
 
GGCAGTTGCAGACCCTCCTTG-3
 
9
 
) and mouse thrombomodulin (5
 
9
 
1.
 
 Abbreviations used in this paper
 
: CMEC, cardiac microvascular endo-
thelial cells; LDL, low density lipoprotein; ONPG, 
 
O
 
-Nitrophenyl-
 
b
 
-
 
d
 
-
galactopyranoside; RT, reverse transcriptase; TM, thrombomodulin;
vWF, von Willebrand factor. 
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ACTGATCGGACGCTGCAGAAGTTCTGA 3
 
9
 
, 5
 
9
 
-GGCCCAGTAT-
GTCTCAAGATAGCAATG-3
 
9
 
). The PCR parameters were 95
 
8
 
C for 3
min, 95
 
8
 
C for 45 s and 72
 
8
 
C for 3.5 min, for a total of 40 cycles, followed by
7 min of elongation at 72
 
8
 
C. PCR products were resolved on a 1.2% aga-
rose gel and visualized with ethidium bromide.
 
Cardiac and Lung Transplantations
 
Cardiac transplantation experiments were performed as previously de-
scribed (Rossi, 1992). Briefly, adult vWF
 
lacZ
 
-2 recipient mice were anes-
thetized with intraperitoneal avertin, one or both ears were cleaned with
70% ethanol and a subdermal incision 2–5 mm in length was made with a
scalpel along the transverse axis of the ear. A pair of microdissection scis-
sors was then used to dissect away intradermal tissue towards the apex of
the ear, creating a subdermal ear pouch. The donor heart was removed
from the wild-type neonates (12–24-h old) and inserted into the ear
pouch. Gentle pressure with delicate curved forceps was then used to ex-
press free air from the pocket and to close the incision. Transplanted mice
were returned to their cages and cared for according to standard proto-
cols. Neonatal wild-type lung tissue was transplanted into the pinna of the
ear of isogeneic adult recipients according to a similar protocol. In mock
transplant experiments, a subdermal ear pouch was created and then
closed as described above without insertion of donor tissue.
 
In Vitro Coculture Assays
 
Cardiac muscular endothelial cells (CMEC) were harvested from neona-
tal and adult mice according to modified protocols (Lodge et al., 1992;
Nishida et al., 1993). Adult hearts were excised from anesthetized mice
and retrogradely perfused with Hanks’ balanced salt solution buffer
through the ascending aorta to remove blood cells. The left ventricle was
separated from remaining heart tissue, stripped of its epicardium and
minced in HBSS containing 40 mg/ml collagenase. The resulting cell sus-
pension was incubated at 37
 
8
 
C in a shaking water bath for 20 min, supple-
mented with trypsin (final concentration 25 mg/ml), incubated for an addi-
tional 15 min at 37
 
8
 
C and then centrifuged at 100 
 
g
 
 for 5 min. The
endothelial cell–rich supernatant was resuspended and plated in DME/
20% FCS. To harvest CMEC from neonatal FVB mice, hearts were re-
moved aseptically from a total of 8–15 mice between 2 and 5 d of age,
placed in ADS buffer (116 mM NaCl, 20 mM Hepes, 1.0 mM NaH
 
2
 
PO
 
4
 
,
5 mM KCl, 0.8 mM Mg
 
2
 
SO
 
4
 
, 5.5 mM glucose), and minced with a straight-
edge razor blade. The tissue was then digested for 45 min at 37
 
8
 
C in DME
supplemented with 5% FCS, 0.2% (wt/vol) collagenase and 0.0005% (wt/
vol) DNase. The cell-rich supernatant was centrifuged at 200 
 
g
 
 for 10 min
and the resulting pellet was resuspended in 2 ml 40% percoll, overlaid
with 2 ml 25% percoll, followed by 2 ml PBS. The gradient was centri-
fuged at 400 
 
g
 
 for 15 min and cells in the 40–25% interface were collected,
pelleted at 200 
 
g
 
 for 2 min, and then resuspended in DME/10% FCS. Cells
were initially plated at a density of 2 
 
3
 
 10
 
5
 
 cells ml and after a 1-h incuba-
tion, the adherent fraction was fed fresh media and subsequently grown at
37
 
8
 
C. After reaching confluence at 7 d, the adult and neonatal CMEC cul-
tures exhibited uniform uptake of Dil-Ac-low density lipoprotein (LDL),
uniformly bound both FITC-conjugated 
 
Griffonia simplicifolia
 
 lectin and
were positive for the endothelial cell marker platelet endothelial cell ad-
hesion molecule–1 (PECAM) (data not shown). In fluorescence-activated
cell sorting studies, 
 
.
 
95% of the cells in the CMEC cultures were positive
for diI-acLDL (data not shown). For endothelial cell–myocyte coculture
assays, ventricular myocytes were harvested from embryonic hearts
(Woodley et al., 1991; Okazaki et al., 1994) and overlaid on established
cultures of CMEC at a ratio of 1:1. To assay for endothelial cell prolifera-
tion, CMEC were cultured alone or cocultured with ventricular myocytes
as described above. After 3 d in culture, the cells were incubated with diI-
acLDL. 12 h later, the diI-acLDL–positive endothelial cells were quanti-
tated and the results were used to calculate the proliferative index. The
proliferative index for CMEC and CMEC in coculture was 3.0 
 
6
 
 0.3 and
2.1 
 
6
 
 0.2, respectively (data not shown). For coculture assays with nonmy-
ocyte cell types, the murine 3T3 fibroblast cell line (CRL 1658), and the
murine BNL CL.2 embryonic hepatocyte cell line (TIB 73) were obtained
from the American Type Culture Collection (Rockville, MD), cultured in
DME/10% FCS and coplated with monolayers of CMEC at a ratio of 1:1.
 
O-Nitrophenyl-
 
b
 
-
 
D
 
-galactopyranoside Assays and 
vWF, TM ELISA
 
CMEC were cultured either alone or in the presence of ventricular myo-
cytes, 3T3 fibroblasts, or BNL hepatocytes for a total of 4 d, and then as-
sayed for 
 
b
 
-galactosidase activity, vWF, and TM. 
 
b
 
-galactosidase activity
was measured using the 
 
O
 
-Nitrophenyl-
 
b
 
-
 
d
 
-galactopyranoside (ONPG)
assay. Cells were washed with PBS, and then incubated with TEN (40 mM
TrisHCl, pH 7.5, 10 mM EDTA, 150 mM NaCl) at room temperature for
10 min. Cells were collected with a cell scraper and centrifuged in an Ep-
pendorf tube at 200 
 
g
 
 for 5 min. The pellet was resuspended in 50 
 
m
 
l lysis
buffer (250 mM TrisHCl, pH 7.8, 10 mM EDTA), freeze-thawed three
times, and then incubated for 1–12 h at 37
 
8
 
C with 150 
 
m
 
l of buffer Z (60
mM dibasic NaHPO
 
4
 
.2H
 
2
 
O, 60 mM monobasic NaHPO
 
4
 
.2H
 
2
 
O, 10 mM
KCl, 1 mM MgSO
 
4
 
, and 50 mM 
 
b
 
-mercaptoethanol), and 50 
 
m
 
l ONPG 4
 
m
 
g/ml in 100 mM NaPO
 
3
 
 buffer, pH 7.0. The A
 
420
 
, A
 
550
 
, and A
 
600
 
 of each
sample was measured by spectrophotometry and 
 
b
 
-galactosidase activity
was calculated as previously described (Miller, 1972). For TM ELISA,
cells were fixed with ice-cold acetone for 2 min, air-dried, washed with
PBS, and then blocked for 1 h with 1% BSA and 0.05% saponin in PBS.
The cells were then washed with PBS and incubated with either anti–
mouse CD31 monoclonal antibody (PharMingen, San Diego, CA) or anti–
human TM (a gift from S. Kennel, University of Tennessee, Oak Ridge, TN)
at a dilution of 1:1,000 for 45 min at room temperature. After five washes
in PBS, the cells were incubated with anti–rat-HRP antibody at a dilution
of 1:500 for 1 h at room temperature. Cells were washed five times with PBS,
and then incubated with 100 
 
m
 
l of solution containing 8 mg orthophe-
nylenediamine (OPD) substrate (Dako Corp., Carpinteria, CA) in 12 ml
0.1 M citric acid-phosphate, pH 5.0, and 0.0125% H
 
2
 
O
 
2
 
 at room tempera-
ture for 3 min. The reaction was stopped with equal volume 1 M sulfuric
acid and the A
 
490
 
 was measured by spectrophotometry. For vWF ELISA,
the cells were fixed with 4% paraformaldeyhde in PBS for 15 min on ice,
washed three times with PBS, and incubated with 1% BSA and 0.05% sa-
ponin in PBS at room temperature for 1 h. After a wash in PBS, the cells
were incubated with vWF-HRP antibody (Dako Corp.) at a dilution of
1:200 for 1 h at room temperature. Cells were washed five times with PBS,
and then incubated with 100 
 
m
 
l of solution containing 8 mg OPD substrate
(Dako Corp.) in 12 ml 0.1 M citric acid phosphate, pH 5.0, and 0.0125%
H
 
2
 
O
 
2
 
 at room temperature for 3 min. The reaction was stopped with equal
volume 1 M sulfuric acid, and the A
 
490
 
 was measured by spectrophotometry.
 
Ribonuclease Protection Assays
 
Template DNA containing sequences from the mouse TM cDNA and
from exon 28 of the mouse vWF gene were subcloned into the Bluescript
vector (Stratagene). The constructs were linearized by restriction diges-
tion with NotI, and then incubated with T7 in the presence of [
 
32
 
P]UTP to
generate single stranded radiolabeled RNA probe. The probe was then
hybridized with 20 
 
m
 
g of total RNA in hybridization buffer at 42
 
8
 
C over-
night and the reaction mixture subsequently treated with RNase and
RNase T1 for 30 min at 37
 
8
 
C. A [
 
32
 
P]UTP-labeled, 250-bp mouse 
 
b
 
-actin
probe was included in each reaction mixture to control for amounts of
RNA. The protected fragments were separated on a 5% nondenaturing
polyacrylamide gel. The gel was then dried and exposed to x-ray film
overnight. The relative intensity of the bands were quantitated with Beta-
scope 603 Blot Analyzer (Betagen, Waltham, MA).
 
Results
 
The vWFlacZ-2 Transgene Is Expressed in the 
Microvascular Bed of the Heart and Skeletal Muscle
 
The limited pattern of transgene expression in mice har-
boring a 733-bp fragment of the human vWF gene sug-
gested that DNA sequences outside this region contained
information for more widespread endothelial cell expres-
sion (Aird et al., 1995). To confirm this speculation, we
generated transgenic mice with a larger segment of the
vWF gene containing 2,182 bp of 5
 
9
 
 flanking sequence, the
first exon, and first intron was coupled to the 
 
LacZ
 
 re-
porter gene (vWF
 
lacZ
 
-2) (Fig. 1). In seven independent
founder lines, the X-Gal reaction product was detected
not only within blood vessels of the brain but also in a sub-
set of microvessels within the heart and skeletal muscle
(Figs. 2, 
 
A–C
 
, and 3). In cardiac sections stained with
X-Gal and then processed for immunoperoxidase detec- 
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tion of endogenous vWF, the transgene and endogenous
gene products colocalized in the endothelial lining of cap-
illary vessels (Fig. 3 
 
B
 
). In contrast, the endothelial cells of
the coronary arteries, coronary veins, penetrating arteries,
and endocardium of the heart exhibited no detectable
 
b
 
-galactosidase activity but possessed immunoreactive
vWF (Fig. 3
 
A
 
, 
 
arrowhead
 
, absence of 
 
LacZ
 
 staining in epi-
cardial coronary artery). Transgene expression was simi-
larly absent in the vascular bed of other organs, including
the liver, spleen, lung, and kidney, as well as in the aorta
and megakaryocyte lineage (Fig. 2, 
 
D–F
 
). In each of the
seven lines of mice, ectopic reporter gene activity was de-
tected within a subpopulation of neurons within the hypo-
thalamus and cerebellum (data not shown). In RT-PCR
analyses, 
 
LacZ
 
 mRNA was detected only in brain, heart,
and skeletal muscle (Fig. 4). In contrast, mRNA from the
endogenous vWF gene and from the endothelial cell-
restricted TM gene was present in all tissues examined.
vWF mRNA levels varied from one organ to another (Fig.
4) and correlated with transcript levels detected by ribonu-
clease protection assays (data not shown). Thus, the above
vascular bed–specific expression pattern of vWF
 
LacZ
 
-2
provides further evidence that the vWF transgene is regu-
lated through the interaction of regional transcriptional
networks with distinct promoter elements.
Figure 1. Schematic representation of the vWFlacZ-2 transgene.
Arrow, transcriptional start site; SV40 poly(A), SV40 polyadeny-
lation signal; RI, EcoRI; H, HindIII; S, SphI.
Figure 2. The vWFlacZ-2 transgene directs vascular bed–specific expression in vivo. LacZ staining of 10-mm sections from vWFlacZ-2
mouse tissues showing reporter gene activity within the endothelial cell lining of a blood vessel in the white matter of the brain (A), and
microvessels of the heart (B) and skeletal muscle (C). In contrast, b-galactosidase activity is not detectable in the lung (D), kidney (E),
and spleen (F). The X-Gal reaction product was similarly absent in other organs, including the liver and aorta as well as the megakaryo-
cyte/platelet lineage (data not shown). Bars: (A) 23 mm; (B–F) 63 mm.
Wild-type Heart Grafts Induce Transgene
Expression in Endothelial Cells Derived from
LacZ-negative Blood Vessels
We then wished to determine the relative importance of
environmental cues and genetic factors in programming
expression of the vWFlacZ-2 transgene in different vascu-
lar beds. To investigate this issue, we used a syngeneic car-
diac transplantation model in which neonatal donor hearts
are grafted into the ear of adult recipient mice (Rossi,
1992). In these experiments, wild-type neonatal were har-
vested within 24 h of birth, and immediately implanted un-
der the subdermal layer of the ear pinna of adult vWFlacZ-2
transgenic mice. The blood vessels of the host ear rapidly
vascularize the graft (Fig. 5 A), and endothelial cells from
this nonexpressing bed are newly exposed to a myocardial
environment. The grafts were analyzed between 3–6 wk
after transplantation when the functional viability of the
implanted organ was confirmed both by visible pulsations
and electrocardiographic activity (Fig. 5 B). In six inde-
pendent transplants, LacZ activity was detected in numer-
ous blood vessels surrounding ventricular myocytes (Fig.
5, C and D). The X-Gal reaction product was not observed
in the vascular bed of the ear proper, nor within the blood
vessels of mock-transplanted transgenic littermates (data
not shown). LacZ staining was also absent in neonatal
lung tissue transplanted into the pinna of six vWFlacZ-2
transgenic mice (Fig. 5 F). As a control for neovasculariza-
tion, wild-type lungs were also grafted into a transgenic
mouse that contains b-galactosidase activity in endothelial
cells of every vascular bed including the ear (Aird, W.C.,
and R.D. Rosenberg, unpublished observations). In these
mice, an abundance of LacZ-positive blood vessels within
the substance of the graft indicate that the transplanted
lung is revascularized by host-derived endothelium (Fig. 5Aird et al. Vascular Bed–specific Regulation of the von Willebrand Factor Gene 1121
E). Taken together, these results suggest that certain vas-
cular beds outside the heart, skeletal muscle, and brain re-
tain the competence to express the vWFlacZ-2 transgene
in response to the microenvironment of the heart. In other
words, the critical information required for cardiac mi-
crovascular–specific transcriptional activation of the vWF
transgene is not contained within the endothelial cell, but
rather within the surrounding myocytes or the extracellu-
lar milieu. These in vivo observations support the view
that organ-specific endothelial cell gene expression is ulti-
mately controlled by the interplay between local environ-
mental factors and intracellular transcriptional networks.
Cardiac Myocytes Induce Expression of Both
Transgene and Endogenous vWF under In Vitro
Coculture Conditions
We next established a coculture system to delineate the in-
teraction between CMEC and ventricular myocytes in-
volved in transgene activation. To this end, neonatal or
adult transgenic CMEC were harvested and grown under
in vitro conditions. After 4 d of culture, pure populations
of CMEC no longer exhibited LacZ activity (data not
shown). However, when overlaid with wild-type ventricu-
lar myocytes, CMEC reacquired the X-Gal reaction prod-
uct. Interestingly, most LacZ-positive endothelial cells oc-
curred within clusters of spontaneously beating ventricular
myocytes (Fig. 6 B). To quantitate the extent of transgene
induction, LacZ activity was assayed in whole plate lysates
with the ONPG substrate. On average, b-galactosidase ac-
tivity in primary cultures of CMEC (120 U/105 cells) was
2.6-fold higher in cocultures of CMEC and myocytes as
compared to CMEC alone (Fig. 6 A). Of importance, the
total numbers of endothelial cells, as monitored by cell-
specific markers, failed to increase upon the addition of
ventricular myocytes which argues against a proliferative
effect of the coculture conditions (data not shown). More-
over, the antigenic levels of the endothelial cell marker
TM were not elevated, suggesting that the inductive pro-
cess is specific for b-galactosidase (Fig. 6 A). Furthermore,
cocultures of CMEC with BNL hepatocytes or 3T3 fibro-
blasts failed to induce LacZ expression (data not shown).
Thus, the above data suggest that maintenance and rein-
duction of the vWFlacZ-2 transgene in CMEC are specifi-
cally mediated by cardiac myocytes.
Finally, we asked whether endothelial cell expression of
the endogenous vWF gene and the vWFlacZ-2 transgene
is controlled in a similar fashion by cardiomyocytes. Pri-
mary cultures of CMEC between passages 1–4, exhibited
barely visible vWF antigen as judged by immunohis-
tochemical staining (data not shown). By comparison,
strongly positive vWF-containing endothelial cells were
readily discernible within clusters of ventricular myocytes
under coculture conditions (Fig. 6 C). Total cellular vWF
antigenic levels in CMEC (1 ng/105 cells) were increased
by an average of 3.1-fold upon addition of cardiomyocytes
(Fig. 6 A), but were not altered in the presence of mouse
hepatocytes or 3T3 cells (data not shown). To exclude the
possibility that a translational mechanism was responsible
for elevating endogenous vWF concentrations, vWF mRNA
levels were determined by ribonuclease protections assays
under coculture conditions. Primary cultures of CMEC ex-
Figure 4. b-galactosidase ac-
tivity correlates with LacZ
mRNA levels. RT-PCR anal-
ysis of LacZ, vWF, and TM
in vWFlacZ-2 mouse tissues
reveals the presence of de-
tectable  b-galactosidase tran-
scripts exclusively within the
brain, heart, and skeletal
muscle of adult transgenic
mice. This limited expres-
sion pattern contrasts with the more widespread, albeit heteroge-
neous, distribution of endogenous vWF and TM mRNA in adult
mouse tissues. Each lane represents an RT-PCR analysis from
identical cDNA template. Two independent experiments in two
independent vWFlacZ-2 transgenic lines produced similar re-
sults.
Figure 3. The vWFlacZ-2 transgene colocalizes with endogenous
vWF within the microvessels of the heart. (A) Whole mounts of
the vWFlacZ-2 adult heart incubated with the X-Gal substrate re-
veals diffuse LacZ staining in both ventricles and atria with dis-
tinct sparing of the epicardial coronary arteries (arrowhead). (B)
10-mm section through the left ventricular wall of the vWFlacZ-2
adult heart processed for b-galactosidase activity (blue) and im-
munoperoxidase detection of vWF (black) reveals co-localization
(arrowheads) within the endothelial lining of the microvessels.
Bar, 26 mm.The Journal of Cell Biology, Volume 138, 1997 1122
Figure 6. Protein expression in cardiac microvas-
cular endothelial cell-ventricular myocyte cocul-
ture. (A) b-Galactosidase activity in CMEC from
vWFlacZ-2 mice, as measured with the ONPG
substrate, was 2.6-fold higher under coculture con-
ditions (CMEC 1 myo) compared with either vWF-
lacZ-2 or wild-type CMEC alone. Antigenic levels
of cellular vWF were stimulated 3.1-fold under
similar conditions. In contrast, there was no
change in the antigenic levels of the endothelial
cell marker TM when CMEC was coplated with
ventricular myocardial cells. The results are de-
rived from at least three independent experiments,
each performed in triplicate. Protein levels are cal-
culated relative to values obtained from primary
cultures of vWFlacZ-2 and wild-type–derived
CMEC. (B) X-Gal staining of a coculture plate
containing CMEC and cardiomyocytes reveals the
presence of numerous LacZ-positive endothelial
cells integrated within a cluster of myocytes. (C)
vWF immunofluorescence under coculture condi-
tions reveals a similar staining pattern with strongly
positive endothelial cells interspersed within a col-
ony of cardiomyocytes. Bar, 100 mm.
Figure 5. Environmental induction of trans-
gene expression in cardiac transplantation
model. (A) Whole mount photomicrograph
of a 3-wk-old neonatal, wild-type cardiac
graft in the ear of an adult vWFlacZ-2
mouse showing the complex network of
anastomosing host auricular blood vessels.
(B) Two-lead electrocardiogram of a trans-
planted heart revealing electrocardio-
graphic activity. The heart rate of the graft
was 150 beats per min, compared with the
native heart rate of 320 beats per min under
anesthesia (C) X-Gal staining of a thick
100-mm section from the cardiac graft re-
veals the presence of b-galactosidase activ-
ity in a linear pattern. (D) X-Gal staining of
an 8-mm section from the cardiac graft re-
veals the presence of LacZ-containing en-
dothelial cells next to wild-type ventricular
myocytes. (E) X-Gal staining of a 12-mm
section through a wild-type lung graft trans-
planted into the ear of a transgenic mouse
that expresses LacZ in all vascular beds.
The presence of LacZ-positive blood ves-
sels indicates that the lung graft is revascu-
larized by host-derived endothelium. (F)
X-Gal staining of a 12-mm section through
a wild-type lung graft in the ear of a vWF-
lacZ-2 mouse ear revealing absence of de-
tectable LacZ activity. Bars: (C,E,F) 60 mm;
(D) 12 mm.Aird et al. Vascular Bed–specific Regulation of the von Willebrand Factor Gene 1123
hibited decreased concentrations of transcript as com-
pared to whole heart or freshly harvested CMEC (Fig. 7).
The addition of ventricular myocytes to CMEC resulted in
a threefold induction of vWF expression (Fig. 7). In con-
trast, TM mRNA levels did not change significantly (Fig. 7).
Discussion
In the present study, a region of the human vWF gene en-
compassing 2,182 bp of 59 flanking sequence, the first exon
and first intron coupled to the coding region of LacZ was
used to generate transgenic mice. In seven independent
lines of mice, reporter gene activity and mRNA were lim-
ited to the endothelial lining of blood vessels in the brain,
heart and skeletal muscle, indicating that this particular
promoter fragment contains information sufficient for vas-
cular bed–specific expression of vWF. The limited distri-
bution of the transgene contrasts with the more wide-
spread expression of the endogenous gene and suggests
that alternative mechanisms of transcriptional activation
are operative in LacZ-negative endothelial cells. These
observations add vWF to a growing list of endothelial cell
promoters that have been shown to direct limited, endo-
thelial cell subtype-restricted expression in transgenic
mice (Harats et al., 1995; Korhonen et al., 1995; Schlaeger
et al., 1995). In one report, DNA promoter constructs con-
taining either 1,200 or 600 bp of the murine Tie-2 pro-
moter were shown to direct expression to distinct endothe-
lial cell subpopulations within transgenic embryos
(Schlaeger et al., 1995). In a similar study, a 735-bp region
of the mouse Tie-1 gene was shown to confer endothelial
cell subtype-specific expression during development (Kor-
honen et al., 1995). In contrast, activity of the Tie-1 and
Tie-2 transgenes was downregulated in adult mice (Kor-
honen et al., 1995; Schlaeger et al., 1995). Finally, a 5.9-kb
fragment of the murine preproendothelin-1 promoter di-
rected differential expression within the endothelium and
vascular smooth muscle cells of adult transgenic mice
(Harats et al., 1995). Expression levels in these mice varied
not only between arteries, veins, and capillaries, but also
between vascular beds of different organs (Harats et al.,
1995). Taken together, these studies provide strong sup-
port for the existence of regional differences in the mecha-
nisms of endothelial cell gene regulation.
The existence of cell subtype-specific mechanisms of
gene regulation is not limited to the endothelium. In trans-
genic mice, the a1(1) collagen gene was shown to possess
different cis elements required for expression in fibro-
blasts of the skin as compared to fibroblasts within the fas-
cia (Liska et al., 1994). In another investigation, expres-
sion of the CD4 gene in transgenic mice was shown to be
governed by distinct regulatory elements in separate T cell
subsets (Hanna et al., 1994). In a recent study of the mus-
cle-specific SM22a gene, a 445-bp region of the promoter
directed expression in the vascular smooth cells of arteries
as well as cardiac and skeletal myocytes in a temporospa-
tial pattern similar to that of the endogenous gene. How-
ever, in contrast to the endogenous gene, transgene ex-
pression was absent in venous and visceral smooth muscle
cells (Li et al., 1996). The promoter region of yet another
muscle-specific gene (MLC-3F) was found to contain dis-
tinct DNA regions capable of distinguishing between reg-
ulatory programs within the various chambers of the trans-
genic heart (Kelly et al., 1995). These reports provide
additional evidence that transcriptional control mecha-
nisms may differ between subpopulations of cells and rein-
forces the notion that not all cell types within a given lin-
eage are alike.
The vWFlacZ-2 transgenic mouse provides a unique
tool with which to study environmental modulation of en-
dothelial gene expression. In cardiac transplantation ex-
periments, endothelial cells derived from LacZ-negative
blood vessels of the ear were shown to express the trans-
gene in the presence of grafted heart tissue. These findings
indicate that endothelial cells of vascular beds outside the
heart, skeletal muscle, and brain retain the competence to
express the vWFlacZ-2 transgene in response to appropri-
ate environmental cues. In other words, the information
for cardiac microvascular bed–specific transcriptional acti-
vation of the vWF transgene is contained not within the
endothelial cell itself but rather within the surrounding
extracellular milieu. The importance of the ventricular
myocyte in mediating the inductive phenomenon was doc-
umented in coculture assays. In these experiments, main-
tenance and reinduction of both vWFlacZ and endoge-
nous vWF gene expression in CMEC was found to be
dependent on cardiomyocyte-derived signals. Taken to-
gether, these observations add strong support to the no-
tion that organ-specific endothelial cell gene expression is
ultimately controlled by interactions between local envi-
ronmental factors and intracellular transcriptional net-
works. Indeed, the in vitro system should prove useful
in identifying and characterizing signaling pathways in-
volved.
In summary, the above data strongly suggest that car-
diac microvascular endothelial cells possess a common
transcriptional mechanism for expressing both endoge-
nous vWF and the vWFlacZ-2 transgene. Based upon
these results, we predict that transcriptional activation of
vWF in LacZ-negative vascular beds is mediated by the in-
teraction of local signaling pathways with cis-acting ele-
ments outside of the vWFlacZ-2 promoter region. Accord-
ing to this model of gene regulation, the expression
pattern of vWF and perhaps other endothelial cell genes
within the vascular tree reflect the combined activity of
multiple signaling pathways that vary from one microenvi-
ronment to another. This array of local networks would
provide an effective means of establishing functionally dis-
tinct endothelial cell populations responsive to the specific
needs of the underlying tissues. As a logical extension of
this model, pathophysiological alterations in one or more
Figure 7. Changes in vWF
antigen correlate with tran-
script levels. In ribonuclease
protection assays, total RNA
from freshly harvested heart
(heart), CMEC and CMEC
in coculture with ventricular
myocytes (CMEC 1 myo) was
hybridized to riboprobes spe-
cific for mouse vWF, TM,
and  b-actin mRNA.The Journal of Cell Biology, Volume 138, 1997 1124
of these pathways might underlie the focal nature of vas-
cular diseases.
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